Harvard Bioscience, Inc.  

(Public, NASDAQ:HBIO)   Watch this stock  
Find more results for HBIO
+0.05 (1.06%)
Real-time:   12:35PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.65 - 4.75
52 week 2.25 - 4.85
Open 4.65
Vol / Avg. 40,941.00/197,133.00
Mkt cap 165.68M
P/E     -
Div/yield     -
EPS -0.09
Shares 34.88M
Beta 1.39
Inst. own 65%
May 18, 2018
Harvard Bioscience Inc Annual Shareholders Meeting (Estimated) - 11:00AM EDT - Add to calendar
Mar 7, 2018
Q4 2017 Harvard Bioscience Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Jan 23, 2018
Harvard Bioscience Inc to Acquire Data Sciences International Inc - M&A Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -1.66% -4.12%
Operating margin -0.54% -2.77%
EBITD margin - 2.98%
Return on average assets -1.52% -3.78%
Return on average equity -2.20% -5.75%
Employees 411 -
CDP Score - -


United States - Map
+1-508-8938999 (Phone)
+1-508-4295732 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.

Officers and directors

James W. Green Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Jeffrey A Duchemin President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Robert E Gagnon Chief Financial Officer
Age: 40
Bio & Compensation  - Reuters
Yong Sun Vice President - Strategic Marketing and Business Development
Age: 51
Bio & Compensation  - Reuters
David M. Green Director
Age: 50
Bio & Compensation  - Reuters
Katherine Anne Eade Independent Director
Bio & Compensation  - Reuters
Neal J. Harte Independent Director
Age: 71
Bio & Compensation  - Reuters
John F. Kennedy Independent Director
Age: 67
Bio & Compensation  - Reuters
Thomas W. Loewald Independent Director
Age: 53
Bio & Compensation  - Reuters